 |
0 Diseases |  |
25 Trials |
|
25 Trials |  |
2418 News |  |
| «12...30313233343536373839404142» |
- | albendazole / Generic mfg.
Enrollment change: RCT ALB for SA Cysticercosis (clinicaltrials.gov) - Jan 30, 2019
P3, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=120 --> 0
- | albendazole / Generic mfg.
Enrollment closed: ITCHHI: Immunisation, Treatment and Controlled Human Hookworm Infection (clinicaltrials.gov) - Dec 24, 2018
P=N/A, N=23, Active, not recruiting, Sponsor: Leiden University Medical Center
N=120 --> 0 Not yet recruiting --> Active, not recruiting
- | albendazole / Generic mfg.
Trial completion: Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji (clinicaltrials.gov) - Dec 6, 2018
P=N/A, N=3424, Completed, Sponsor: Washington University School of Medicine
Not yet recruiting --> Active, not recruiting Enrolling by invitation --> Completed
- | albendazole / Generic mfg.
Trial initiation date: Efficacy and Safety of IVM/ALB Co-administration (clinicaltrials.gov) - Dec 4, 2018
P2/3, N=1960, Not yet recruiting, Sponsor: Jennifer Keiser
Enrolling by invitation --> Completed Initiation date: Sep 2018 --> Apr 2019
- | albendazole / Generic mfg.
Enrollment open: Albendazole Dose Finding and Pharmacokinetics in Children and Adults (clinicaltrials.gov) - Dec 4, 2018
P2, N=1040, Recruiting, Sponsor: Jennifer Keiser
Initiation date: Sep 2018 --> Apr 2019 Not yet recruiting --> Recruiting
- | albendazole / Generic mfg.
Trial primary completion date: Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana (clinicaltrials.gov) - Oct 11, 2018
P3, N=375, Active, not recruiting, Sponsor: University Hospitals Cleveland Medical Center
Not yet recruiting --> Recruiting Trial primary completion date: Oct 2018 --> Jul 2018
- | albendazole / Generic mfg.
Trial completion date, Trial primary completion date: Lymphatic Filariasis (LF) in Ivory Coast (clinicaltrials.gov) - Oct 11, 2018
P=N/A, N=189, Active, not recruiting, Sponsor: University Hospitals Cleveland Medical Center
Trial primary completion date: Oct 2018 --> Jul 2018 Trial completion date: Aug 2018 --> Dec 2018 | Trial primary completion date: Aug 2015 --> Sep 2018
- | albendazole / Generic mfg.
New trial: ITCHHI: Immunisation, Treatment and Controlled Human Hookworm Infection (clinicaltrials.gov) - Oct 11, 2018
P=N/A, N=24, Not yet recruiting, Sponsor: Leiden University Medical Center
- | albendazole / Generic mfg.
Trial completion: Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa (clinicaltrials.gov) - Oct 9, 2018
P2, N=182, Completed, Sponsor: University Hospitals Cleveland Medical Center
Trial completion date: Aug 2018 --> Dec 2018 | Trial primary completion date: Aug 2015 --> Sep 2018 Active, not recruiting --> Completed
- | albendazole / Generic mfg.
Enrollment status: Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji (clinicaltrials.gov) - Oct 2, 2018
P=N/A, N=4000, Enrolling by invitation, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Recruiting --> Enrolling by invitation
- | albendazole / Generic mfg., azithromycin / Generic mfg.
New P3 trial: Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) (clinicaltrials.gov) - Sep 17, 2018
P3, N=20000, Not yet recruiting, Sponsor: Lihir Medical Centre
- | albendazole / Generic mfg., azithromycin / Generic mfg.
New P2 trial: PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs ) (clinicaltrials.gov) - Sep 9, 2018
P2, N=42, Not yet recruiting, Sponsor: Lihir Medical Centre
- | albendazole / Generic mfg., azithromycin / Generic mfg.
Trial initiation date: Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin (clinicaltrials.gov) - Sep 5, 2018
P4, N=16000, Not yet recruiting, Sponsor: London School of Hygiene and Tropical Medicine
Recruiting --> Enrolling by invitation Initiation date: Aug 2018 --> Nov 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: TUMIKIA: Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in Kenya (clinicaltrials.gov) - Aug 31, 2018
P4, N=21761, Completed, Sponsor: London School of Hygiene and Tropical Medicine
Initiation date: Aug 2018 --> Nov 2018 Recruiting --> Completed | Trial completion date: Dec 2017 --> Jul 2017
- | moxidectin / Generic mfg., albendazole / Generic mfg.
Trial completion: MOXIDOSE: Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura (clinicaltrials.gov) - Aug 14, 2018
P2, N=286, Completed, Sponsor: Swiss Tropical & Public Health Institute
Recruiting --> Completed | Trial completion date: Dec 2017 --> Jul 2017 Not yet recruiting --> Completed
- | albendazole / Generic mfg.
Trial initiation date: Efficacy and Safety of IVM/ALB Co-administration (clinicaltrials.gov) - Aug 13, 2018
P2/3, N=1960, Not yet recruiting, Sponsor: Jennifer Keiser
Not yet recruiting --> Completed Initiation date: Jun 2018 --> Sep 2018
- | albendazole / Generic mfg.
New trial: TB-LION: Tuberculosis - Learning the Impact of Nutrition (clinicaltrials.gov) - Jul 26, 2018
P=N/A, N=120, Not yet recruiting, Sponsor: Boston Medical Center
- | albendazole / Generic mfg., azithromycin / Generic mfg.
New P4 trial: Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin (clinicaltrials.gov) - Jun 27, 2018
P4, N=16000, Not yet recruiting, Sponsor: London School of Hygiene and Tropical Medicine
- | albendazole / Generic mfg.
New P2/3 trial: Efficacy and Safety of IVM/ALB Co-administration (clinicaltrials.gov) - May 18, 2018
P2/3, N=1960, Not yet recruiting, Sponsor: Jennifer Keiser
- | albendazole / Generic mfg.
New P2 trial: Albendazole Dose Finding and Pharmacokinetics in Children and Adults (clinicaltrials.gov) - May 18, 2018
P2, N=1040, Not yet recruiting, Sponsor: Jennifer Keiser
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: DOLF-LIBERIA: Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia (clinicaltrials.gov) - May 4, 2018
P=N/A, N=17066, Completed, Sponsor: Washington University School of Medicine
Initiation date: Jun 2018 --> Sep 2018 Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jul 2017
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast) (clinicaltrials.gov) - May 4, 2018
P=N/A, N=14457, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jul 2017 Recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2017
- | moxidectin / Generic mfg., albendazole / Generic mfg.
New P2 trial: MOXIDOSE: Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura (clinicaltrials.gov) - Apr 17, 2018
P2, N=280, Not yet recruiting, Sponsor: Swiss Tropical & Public Health Institute
- | albendazole / Generic mfg.
Enrollment open: Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH) (clinicaltrials.gov) - Mar 29, 2018
P4, N=240000, Recruiting, Sponsor: Natural History Museum, United Kingdom
Recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2017 Not yet recruiting --> Recruiting
- | albendazole / Generic mfg.
Biomarker, New trial: StarwormsWP1: Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic Resistance (clinicaltrials.gov) - Mar 13, 2018
P=N/A, N=1000, Recruiting, Sponsor: University Ghent
- | albendazole / Generic mfg.
Trial primary completion date: Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=4000, Recruiting, Sponsor: Washington University School of Medicine
Not yet recruiting --> Recruiting Trial primary completion date: Nov 2017 --> Nov 2017
- | albendazole / Generic mfg.
Trial completion date, Trial initiation date, Trial primary completion date: Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults (clinicaltrials.gov) - Feb 28, 2018
P2, N=200, Not yet recruiting, Sponsor: Robert Gilman
Trial primary completion date: Nov 2017 --> Nov 2017 Initiation date: Nov 2017 --> Nov 2018 | Trial primary completion date: Aug 2018 --> Aug 2019 | Trial completion date: Feb 2019 --> Feb 2020
- | Enrollment open, Trial initiation date, Trial primary completion date: Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection (clinicaltrials.gov) - Feb 26, 2018
P2, N=48, Recruiting, Sponsor: Baylor College of Medicine
Initiation date: Nov 2017 --> Nov 2018 | Trial primary completion date: Aug 2018 --> Aug 2019 | Trial completion date: Feb 2019 --> Feb 2020 Not yet recruiting --> Recruiting | Initiation date: Jan 2018 --> Mar 2018 | Trial primary completion date: Jun 2019 --> Aug 2019
- | albendazole / Generic mfg.
New P2 trial: Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults (clinicaltrials.gov) - Feb 19, 2018
P2, N=250, Not yet recruiting, Sponsor: Oxfendazole Development Group
- | Trial initiation date, Trial primary completion date: Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection (clinicaltrials.gov) - Dec 13, 2017
P2, N=48, Not yet recruiting, Sponsor: Baylor College of Medicine
Not yet recruiting --> Recruiting | Initiation date: Jan 2018 --> Mar 2018 | Trial primary completion date: Jun 2019 --> Aug 2019 Initiation date: Jul 2017 --> Jan 2018 | Trial primary completion date: Dec 2018 --> Jun 2019
- | albendazole / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date: Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis (clinicaltrials.gov) - Oct 25, 2017
P=N/A, N=23789, Active, not recruiting, Sponsor: Washington University School of Medicine
Initiation date: Jul 2017 --> Jan 2018 | Trial primary completion date: Dec 2018 --> Jun 2019 Recruiting --> Active, not recruiting | N=38000 --> 23789 | Trial primary completion date: Jul 2017 --> Apr 2018
- | Enrollment open: Tricombi: Triple Combinations Against Hookworm Infections in Lao (clinicaltrials.gov) - Oct 13, 2017
P4, N=420, Recruiting, Sponsor: Swiss Tropical & Public Health Institute
Recruiting --> Active, not recruiting | N=38000 --> 23789 | Trial primary completion date: Jul 2017 --> Apr 2018 Not yet recruiting --> Recruiting
- | albendazole / Generic mfg.
Trial initiation date, Trial primary completion date: Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH) (clinicaltrials.gov) - Sep 14, 2017
P4, N=240000, Not yet recruiting, Sponsor: Natural History Museum, United Kingdom
Not yet recruiting --> Recruiting Initiation date: Mar 2017 --> Nov 2017 | Trial primary completion date: Mar 2022 --> Dec 2022
- | New P4 trial: Tricombi: Triple Combinations Against Hookworm Infections in Lao (clinicaltrials.gov) - Sep 10, 2017
P4, N=420, Not yet recruiting, Sponsor: Swiss Tropical & Public Health Institute
- | albendazole / Generic mfg.
Trial completion, Enrollment change: Ivermectin Versus Albendazole for Chronic Strongyloidiasis (clinicaltrials.gov) - Sep 7, 2017
P3, N=90, Completed, Sponsor: Mahidol University
Initiation date: Mar 2017 --> Nov 2017 | Trial primary completion date: Mar 2022 --> Dec 2022 Enrolling by invitation --> Completed | N=72 --> 90
- | albendazole / Generic mfg.
Trial completion: Postpartum Deworming: Improving Breastfeeding and Optimizing Infant Growth (clinicaltrials.gov) - Aug 29, 2017
P4, N=1010, Completed, Sponsor: McGill University Health Center
Enrolling by invitation --> Completed | N=72 --> 90 Active, not recruiting --> Completed
- | albendazole / Generic mfg.
Enrollment open: BEED: The Bangladesh Environmental Enteric Dysfunction Study (clinicaltrials.gov) - Aug 17, 2017
P=N/A, N=1575, Recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | albendazole / Generic mfg.
New P3 trial: IVM Alone vs ALB + IVM Against Onchocerciasis (clinicaltrials.gov) - Aug 2, 2017
P3, N=272, Completed, Sponsor: University Hospitals Cleveland Medical Center
- | albendazole / Generic mfg.
Enrollment closed, Trial primary completion date: Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana (clinicaltrials.gov) - Jul 27, 2017
P3, N=375, Active, not recruiting, Sponsor: University Hospitals Cleveland Medical Center
Not yet recruiting --> Recruiting Not yet recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Oct 2018
- | albendazole / Generic mfg.
Enrollment open: Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji (clinicaltrials.gov) - Jul 18, 2017
P=N/A, N=4000, Recruiting, Sponsor: Washington University School of Medicine
Not yet recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Oct 2018 Not yet recruiting --> Recruiting
- | albendazole / Generic mfg.
Trial completion: Effect of Routine Deworming on Weight of Children (clinicaltrials.gov) - Jul 12, 2017
P=N/A, N=300, Completed, Sponsor: Dow University of Health Sciences
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | albendazole / Generic mfg.
New P1 trial: Serum Pharmacokinetic Disposition and Urinary Excretion of Albendazole (clinicaltrials.gov) - Jun 20, 2017
P1, N=8, Completed, Sponsor: Universidad Nacional de Salta
- | albendazole / Generic mfg.
New trial: Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji (clinicaltrials.gov) - Jun 5, 2017
P=N/A, N=4000, Not yet recruiting, Sponsor: Washington University School of Medicine
- | New P2 trial: Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection (clinicaltrials.gov) - May 31, 2017
P2, N=48, Not yet recruiting, Sponsor: Baylor College of Medicine
- | albendazole / Generic mfg., primaquine / Generic mfg.
Trial completion, Trial primary completion date: Pharmacokinetic and Mosquito-Lethal Effects of Ivermectin (IVM), Primaquine (PQ), Dihydroartemisinin-Piperaquine (DHA-PQP) and Albendazole (ABZ) in Healthy Subjects (clinicaltrials.gov) - May 31, 2017
P1, N=16, Completed, Sponsor: University of Oxford
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Sep 2016 --> Dec 2016
- | ivermectin oral / Generic mfg., albendazole / Generic mfg.
Enrollment closed: DOLF-LIBERIA: Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia (clinicaltrials.gov) - May 25, 2017
P=N/A, N=15600, Active, not recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Completed | Trial primary completion date: Sep 2016 --> Dec 2016 Recruiting --> Active, not recruiting
- | albendazole / Generic mfg.
Enrollment open: Twice Yearly Treatment for the Control of LF (clinicaltrials.gov) - May 25, 2017
P4, N=1440, Recruiting, Sponsor: Noguchi Memorial Institute for Medical Research
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | albendazole / Generic mfg.
New trial: Effect of Routine Deworming on Weight of Children (clinicaltrials.gov) - May 15, 2017
P=N/A, N=300, Active, not recruiting, Sponsor: Dow University of Health Sciences
- | albendazole / Generic mfg.
Trial initiation date: Twice Yearly Treatment for the Control of LF (clinicaltrials.gov) - Apr 17, 2017
P4, N=1440, Not yet recruiting, Sponsor: Noguchi Memorial Institute for Medical Research
Not yet recruiting --> Recruiting Initiation date: Mar 2017 --> Jun 2017
- | albendazole / Generic mfg., sulfadoxine/pyrimethamine / Generic mfg., azithromycin / Generic mfg.
New trial: Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi) (clinicaltrials.gov) - Mar 13, 2017
P=N/A, N=1514, Recruiting, Sponsor: Washington University School of Medicine